Publications directory

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 289

Cover image of 'R-CHOP chemotherapy [Romanian]'

R-CHOP chemotherapy [Romanian] (October 2018)

Macmillan Cancer Support

R-CHOP is a combination treatment used to treat non-Hodgkin lymphoma (NHL). This factsheet describes the drugs used, how they are given and the possible side-effects.

Cover image of 'Carboplatin [Slovak]'

Carboplatin [Slovak] (May 2018)

Macmillan Cancer Support

Carboplatin is a chemotherapy drug used to treat ovarian and lung cancer. It may also be used to treat other cancers. 

Cover image of 'Etoposide (Etopophos®, Vepesid®) (French)'

Etoposide (Etopophos®, Vepesid®) (French) (March 2018)

Macmillan Cancer Support

Etoposide is a chemotherapy drug used to treat many types of cancer. This information describes how it is given and some of the possible side-effects.

Cover image of 'Ifosfamide [French]'

Ifosfamide [French] (March 2018)

Macmillan Cancer Support

Ifosfamide is a chemotherapy drug used to treat different cancers including testicular cancer and some types of soft tissue and bone sarcoma. It may also be used to treat other cancers.This factsheet describes how it is given and the possible side-effects.

Cover image of 'Understanding chemotherapy'

Understanding chemotherapy (September 2018)

Macmillan Cancer Support

This booklet is about chemotherapy. It is for anyone who is having chemotherapy treatment for cancer. There is also information for carers, family members and friends. It explains how chemotherapy works and how it is given. There is also information about common side effects, how they can be treated and what you can do to manage them.

Cover image of 'GemCis chemotherapy [Polish]'

GemCis chemotherapy [Polish] (June 2018)

Macmillan Cancer Support

This is a translation of information from the Macmillan Cancer Support website. It describes the GemCis chemotherapy regimen to treat many cancers, the drugs, how treatment is given, and possible side-effects.

Cover image of 'GemCis chemotherapy [Russian]'

GemCis chemotherapy [Russian] (June 2018)

Macmillan Cancer Support

This is a translation of information from the Macmillan Cancer Support website. It describes the GemCis chemotherapy regimen to treat many cancers, the drugs, how treatment is given, and possible side-effects.

Cover image of 'GemCis chemotherapy [Turkish]'

GemCis chemotherapy [Turkish] (June 2018)

Macmillan Cancer Support

This is a translation of information from the Macmillan Cancer Support website. It describes the GemCis chemotherapy regimen to treat many cancers, the drugs, how treatment is given, and possible side-effects.

Cover image of 'ATRA and anthracycline based therapy for acute myeloid leukaemia (AML). A guide for patients'

ATRA and anthracycline based therapy for acute myeloid leukaemia (AML). A guide for patients (March 2018)

Leukaemia Care

All-trans retinoic acid (ATRA), known as Tretinoin (Vesanoid®) is the acid form of vitamin A, which is used with chemotherapy for induction of remission in patients with confirmed acute promyelocytic leukaemia (APL), a subtype of acute myeloid leukaemia. This booklet describes the use of ATRA along with the chemotherapy drugs idarubicin and mitoxantrone.

Cover image of 'DA (Daunarubicin) and ARAc for acute myeloid leukaemia. A guide for patients'

DA (Daunarubicin) and ARAc for acute myeloid leukaemia. A guide for patients (December 2018)

Leukaemia Care

This booklet describes DA treatment, a combination of the drugs daunorubicin and cytarabine (Ara-C), used primarily as induction chemotherapy in patients with newly diagnosed acute myeloid meukaemia. It describes how DA is given, and the possible side-effects. Includes a glossary and details of further support and information.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm